By Lucia Osborne-Crowley ( March 11, 2026, 5:41 PM GMT) -- Shareholders have settled their dispute with U.K.-based drug company Biogen for allegedly failing to make a $50 million payment under a deal to acquire the company and its nerve pain medication, according to court documents....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.